With the advent of Google Glasses and self-quantifying apps (mobile apps that monitor vital signs or other information about the user), wearable technology will soon be a big thing in healthcare. The movement for self-quantifying patients is not too old. Many experts believe that self-quantifying patients are the logical next…
Read more »
By: Dr. Swapan Samanta
Actinomycosis is a chronic suppurative granulomatous inflammatory disease caused by different Actinomyces species, mainly Actinomyces israelii. It is an anaerobic gram-positive bacteria. The intra-abdominal location of this infection is …
The global burden of diabetes mellitus (DM) and tuberculosis (TB) is huge. Nearly one-third of world’s population is infected with Mycobacterium tuberculosis and about 10% of them are at risk of developing active form of the disease in their lifetime depending upon the interaction of the epidemiological triad.
Read more »
Diabetes Mellitus (DM) almost triples the risk of developing tuberculosis (TB) [1]–[4]. India, the nation with the highest number of TB cases in the world, is also undergoing epidemic growth in DM rates. The estimated prevalence of DM in India in 2010 was 51 million and this is projected to increase to 70 million by 2025 [5], [6]. In India, 15% of pulmonary tuberculosis cases have been estimated to be attributable to DM.
Read more »
Ischaemic heart disease (IHD) and stroke are leading causes of death in India, and hypertension is thought to be their main risk factor [1]. The World Health Organization (WHO) estimates that nearly half of these deaths occur among adults aged 30 to 69 years old [2]. The prevalence of hypertension has risen exponentially in India over the past three decades, from less than 5% of adults to over 25% of urban and 10% of rural adults today.
Read more »Below are links to recent news articles of interest to the medical community in India. Please share your comments below – or you can share links to other useful articles that you have read as well.
Read more »
indicates a Peer-Reviewed Article
Statins decrease neuroinflammation and prevent cognitive impairment after cerebral malaria
The burden of malaria is enormous with more than 40% of the world’s population at risk for infections caused by Plasmodium parasites [1]. P. falciparum is the principal cause of syndromes of severe malaria, including cerebral malaria, which involves neurologic and systemic manifestations and in which coma is the defining feature [2]. While only about 1% of P. falciparum infections progress to cerebral malaria, mortality is around 10–20% of affected patients.
Read more »